Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy

Rheumatology (United Kingdom)

Volumn 53, Issue 2, 2014, Pages 332-337

  Varley, Cara D ^a   Deodhar, Atul A ^a   Ehst, Benjamin D ^a   Bakke, Antony ^a   Blauvelt, Andrew ^a   Vega, Robert ^b   Yamashita, Shellie ^a   Winthrop, Kevin L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon State Public Health Laboratory   (United States)

Author keywords

Biologic therapy; Psoriasis; Rheumatoid arthritis; Staphylococcus aureus; Tumour necrosis factor alpha

Indexed keywords

ABATACEPT; ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; METICILLIN; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; USTEKINUMAB;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; IMMUNE MEDIATED INFLAMMATORY DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

BIOLOGIC THERAPY; PSORIASIS; RHEUMATOID ARTHRITIS; STAPHYLOCOCCUS AUREUS; TUMOUR NECROSIS FACTOR-ALPHA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RHEUMATIC FEVER; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84892502226     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket351     Document Type: Article

References (20)

1. Mutru O, Laakso M, Isomaki H et al. Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) 1985;290:1797-9.
2. Doran MF, Crowson CS, Pond GR et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-93.
3. Kroesen S, Widmer AF, Tyndall A et al. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology 2003;42:617-21.
4. Wolfe F, Mitchell DM, Sibley JT et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
5. Dixon WG, Symmons DP, Lunt M et al. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum 2007;56: 2896-904.
6. Winthrop KL. Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2006;2:602-10.
7. Vaudaux P, Grau GE, Huggler E et al. Contribution of tumor necrosis factor to host defense against staphylococci in a guinea pig model of foreign body infections. J Infect Dis 1992;166:58-64.
8. Gorwitz RJ, Kruszon-Moran D, McAllister SK et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008;197:1226-34.
9. Gorwitz RJ, Jernigan DB, Powers JH et al. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention, 2006. http://www.cdc. gov/ncidod/dhqp/ar_mrsa_ca.html (14 October 2013, date last accessed).
10. Honda H, Krauss MJ, Coopersmith CM et al. Staphylococcus aureus nasal colonization and subsequent infection in ICU patients: does methicillin resistance matter? Infect Control Hosp Epidemiol 2010;31:584-91.
11. Szumowski JD, Wener KM, Gold HS et al. Methicillinresistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIVinfected men who have sex with men. Clin Infect Dis 2009; 49:118-21.
12. Nouwen J, Schouten J, Schneebergen P et al. Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J Clin Microbiol 2006;44:2233-6.
13. Jackson MS, Bagg J, Gupta MN et al. Oral carriage of staphylococci in patients with rheumatoid arthritis. Rheumatology 1999;38:572-5.
14. Tabarya D, Hoffman WL. Staphylococcus aureus nasal carriage in rheumatoid arthritis: antibody response to toxic shock syndrome toxin-1. Ann Rheum Dis 1996;55: 823-8.
15. Bassetti S, Wasmer S, Hasler P et al. Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol 2005;32: 2125-9.
16. Balci DD, Duran N, Ozer B et al. High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis. Eur J Dermatol 2009;19: 238-42.
17. Tomi NS, Kranke B, Aberer E. Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. J Am Acad Dermatol 2005;53:67-72.
18. Desrosiers M, Hussain A, Frenkiel S et al. Intranasal corticosteroid use is associated with lower rates of bacterial recovery in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2007;136:605-9.
19. Eveillard M, de Lassence A, Lancien E et al. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006;27: 181-4.
20. Seybold U, Schubert S, Bogner JR et al. Staphylococcus aureus infection following nasal colonization: an approach to rapid risk stratification in a university healthcare system. J Hosp Infect 2011;79:297-301.